Clinical Trials in Philadelphia

Showing 4841-4860 of 15,860 trials

The Opening Doors to Early Intervention Study

NCT03625115

Poor urban minority children often experience delays in their early development leading to health disparities. Publicly funded early intervention services are available to improve child development among these children in Philadelphia, but few children access and complete these services. This can be due to parents misunderstanding what the services include or may be due to difficulties parents experience in overcoming barriers to participating. This study will test the effectiveness of the Opening Doors to Early Intervention Program, a patient navigation intervention designed to improve families' engagement with early intervention services and overcome barriers to access these services, on early child development.

Development DelayDevelopment, Child

Children's Hospital of Philadelphia357 participantsStarted Sep 2018

Philadelphia, Pennsylvania, United States

COMPLETED< 1 mile

Surveillance and Alert-based Multiparameter Monitoring to Reduce Worsening Heart Failure Events

NCT04882449

The main goal of this study is to use data from the Bodyport Cardiac Scale to help detect of worsening heart failure (HF) early.

Heart Failure

Bodyport Inc.329 participantsStarted Jul 2021

Boynton Beach, Florida, United States • Panama City, Florida, United States • Gainesville, Georgia, United States +5 more locations

The Opening Doors to Early Intervention Study

Surveillance and Alert-based Multiparameter Monitoring to Reduce Worsening Heart Failure Events

Find Trials by Condition in Philadelphia

NB-001 in Children and Adolescents With 22q11 Deletion Syndrome

(Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations

A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Upadacitinib in Pediatric Participants With Severe Atopic Dermatitis

PRogrammed Versus Modified Natural Cycle After Euploid Failed Embryo Transfer

Selumetinib and Cyclosporine in Treating Patients With Advanced Solid Tumors or Advanced or Metastatic Colorectal Cancer

A Study of Olaparib and Low Dose Radiotherapy for Small Cell Lung Cancer

A Clinical Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of PGDM1400LS Alone and in Combination With VRC07-523LS and PGT121.414.LS in Healthy, HIV-uninfected Adult Participants

Study of ExoFlo for the Treatment of Medically Refractory Crohn's Disease

A Follow up Study of Patients Treated With Imlifidase Prior to Kidney Transplantation

A Study of ERAS-007 in Patients With Advanced Gastrointestinal Malignancies

A Study of AK117 in Combination With Azacitidine in Patients With Myelodysplastic Syndromes

Non-comparative Study of IFX-1 Alone or IFX-1+Pembrolizumab in Patients With Locally Advanced or Metastatic cSCC.

A Study of SGN-ALPV in Advanced Solid Tumors

LDK378 Versus Chemotherapy in ALK Rearranged (ALK Positive) Patients Previously Treated With Chemotherapy (Platinum Doublet) and Crizotinib

A Trial of a Novel XPO1 Inhibitor in Participants With Advanced Solid Tumors

Evaluation of SAR408701 in Patients With Advanced Solid Tumors

A Study of the Safety and Tolerability in Participants With PIK3CA-related Overgrowth Spectrum or Proteus Syndrome Who Are Being Treated With Miransertib (MK-7075) in Other Studies (MK-7075-006)

Foot and Ankle Post-operative Oedema Management Using Geko™